Detalhe da pesquisa
1.
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.
Pharmaceuticals (Basel)
; 16(5)2023 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37242495